[1]高俊凤,严军,胡春平,等.二甲双胍对胰岛素抵抗小鼠肝组织中胎球蛋白A 表达及磷脂酰肌醇3-激酶/蛋白激酶B 信号通路的影响[J].新乡医学院学报,2022,39(12):1107-1112.[doi:10.7683/xxyxyxb.2022.12.002]
　GAO Junfeng,YAN Jun,HU Chunping,et al.Effect of metformin on the expression of fetuin A and phosphatidylinositol 3-kinase/protein kinase B signal pathway in the liver tissue of insulin resistant mice[J].Journal of Xinxiang Medical University,2022,39(12):1107-1112.[doi:10.7683/xxyxyxb.2022.12.002]
点击复制

二甲双胍对胰岛素抵抗小鼠肝组织中胎球蛋白A 表达及磷脂酰肌醇3-激酶/蛋白激酶B 信号通路的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年12
页码:
1107-1112
栏目:
基础研究
出版日期:
2022-12-05

文章信息/Info

Title:
Effect of metformin on the expression of fetuin A and phosphatidylinositol 3-kinase/protein kinase B signal pathway in the liver tissue of insulin resistant mice
作者:
高俊凤1; 2; 严军2; 胡春平2; 冯珍凤2; 刘曼曼2
（1.上海中医药大学研究生院，上海　201203；2.上海市嘉定区中医医院内分泌科，上海　201899）
Author(s):
GAO Junfeng1; 2; YAN Jun2; HU Chunping2; FENG Zhenfeng2; LIU Manman2
(1.Graduate School,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China；2.Department of Endocrinology,Traditional Chinese Medicine Hospital of Jiading District of Shanghai,Shanghai 201899,China)
关键词:
二甲双胍; 胰岛素抵抗; 胎球蛋白A; 磷脂酰肌醇3-激酶/蛋白激酶B 信号通路
Keywords:
metformin; insulin resistance; fetuin A; phosphatidylinositol 3-kinase/protein kinase B signal pathway
分类号:
R587.1
DOI:
10.7683/xxyxyxb.2022.12.002
文献标志码:
A
摘要:
目的　探讨二甲双胍对胰岛素抵抗（IR）小鼠肝组织中胎球蛋白A （FA）表达及磷脂酰肌醇3-激酶(PI3K)/蛋白激酶B （Akt）信号通路的影响。方法　将30只无特定病原体级健康雄性小鼠适应性喂养1周后，随机选择10只小鼠为正常组，给予普通饲料喂养8周；另外20只小鼠给予高脂饲料喂养8周，制备IR模型。将造模成功的16只小鼠随机分为模型组(n=8)和二甲双胍组(n=8)，二甲双胍组小鼠给予二甲双胍灌胃，102.75 mg·kg-1,每日1次，连续给药4周；正常组和模型组小鼠给予同等剂量的生理盐水灌胃。造模8周期间和给药4周期间，每周称量小鼠体质量。给药4周后，3组小鼠禁食12 h，采用腹腔注射葡萄糖耐量实验(IPGTT)检测小鼠糖耐量。给药4周后，使用小鼠胰岛素酶联免疫吸附试验法测定小鼠血清空腹胰岛素(FINS)水平，并计算稳态模型评估-胰岛素抵抗指数（HOMA-IR）；采用实时荧光定量聚合酶链式反应法检测小鼠肝组织中胎球蛋白A（FA）、PI3K、Akt mRNA相对表达量；采用Western blot法检测小鼠肝组织中FA、PI3K、磷酸化PI3K（p-PI3K）、Akt、磷酸化Akt（p-Akt）蛋白相对表达量。结果　造模8周后，模型组和二甲双胍组小鼠的体质量显著高于正常组（P<0.05）；给药1、2、3、4周后，模型组和二甲双胍组小鼠的体质量显著高于正常组（P<0.05）；给药3、4周后，二甲双胍组小鼠的体质量显著低于模型组（P<0.05）。给药4周后，模型组和二甲双胍组小鼠的IPGTT曲线下面积显著高于正常组，二甲双胍组小鼠的IPGTT曲线下面积显著低于模型组（P<0.05）。给药4周后，模型组小鼠的FINS水平及HOMA-IR显著高于正常组和二甲双胍组 (P<0.05)；给药4周后，二甲双胍组与正常组小鼠的FINS水平及HOMA-IR比较差异无统计学意义（P>0.05）。给药4周后，模型组小鼠肝组织中FA、PI3K、Akt mRNA相对表达量及FA蛋白相对表达量显著高于正常组和二甲双胍组，p-PI3K/PI3K、p-Akt/Akt显著低于正常组和二甲双胍组 (P<0.05)；二甲双胍组与正常组小鼠肝组织中FA、PI3K、Akt mRNA相对表达量、FA蛋白相对表达量及p-PI3K/PI3K、p-Akt/Akt比较差异无统计学意义（P>0.05）。结论　二甲双胍可改善IR小鼠的肥胖状态，提高机体对血糖浓度的调节能力，降低FINS水平及HOMA-IR，其机制可能为二甲双胍通过降低肝脏FA表达，激活PI3K/Akt通路，从而缓解IR。
Abstract:
Objective　To investigate the effect of metformin on the expression of fetuin A (FA) and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signal pathway in the liver tissue of insulin resistant (IR) mice.Methods　Thirty healthy male mice without specific pathogens were adaptively fed for one week,then 10 mice were randomly selected as the normal group,fed with normal diet for 8 weeks,and the other 20 mice were fed with high-fat diet for 8 weeks to prepare the IR model.Sixteen mice with successful IR model were randomly divided into the model group (n=8) and the metformin group (n=8).The mice in the metformin group were given metformin by gavage,102.75 mg·kg-1,once a day,for 4 consecutive weeks;the mice in normal group and the model group were given the same dose of normal saline by gavage.During the 8-week modeling period and the 4-week administration period,the body weight of mice was weighed weekly.After 4 weeks of administration,the mice in the three groups were fasted for 12 hours,then the glucose tolerance was measured by intraperitoneal injection glucose tolerance test (IPGTT).After 4 weeks of administration,the level of fasting insulin (FINS) in serum of mice was measured with insulin enzyme-linked immunosorbent assay method,and the homeostasis model assessment-estimated insulin resistance (HOMA-IR) was calculated;the relative expression of fetuin A (FA),PI3K,Akt mRNA in liver tissue of mice was detected by real-time fluorescence quantitative polymerase chain reaction;the relative expression of FA,PI3K,phosphorylated PI3K (p-PI3K),Akt and phosphorylated Akt (p-Akt) in liver tissue of mice was detected by Western blot.Results　After 8 weeks of modeling,the body weight of mice in the model group and the metformin group was significantly higher than that in the normal group (P<0.05);after 1,2,3,4 weeks of administration,the body weight of mice in the model group and metformin group was significantly higher than that in the normal group (P<0.05);after 3 and 4 weeks of administration,the body weight of mice in the metformin group was significantly lower than that in model group (P<0.05).After 4 weeks of administration,the area under the curve of IPGTT of mice in the model group and metformin group was significantly higher than that in the normal group(P<0.05),and the area under the curve of IPGTT of mice in the metformin group was significantly lower than that in the model group (P<0.05).After 4 weeks of administration,the FINS level and HOMA-IR of mice in the model group were significantly higher than those in the normal group and metformin group (P<0.05);after 4 weeks of administration,there was no significant difference in FINS level and HOMA-IR between the metformin group and the normal group (P>0.05).After 4 weeks of administration,the relative expression of FA,PI3K,Akt mRNA and FA protein in liver tissues of mice in the model group were significantly higher than those in the normal group and metformin group,while p-PI3K/PI3K and p-Akt/Akt in liver tissues of mice in the model group were significantly lower than those in the normal group and metformin group (P<0.05);there was no significant difference in the relative expression of FA,PI3K,Akt mRNA,FA protein and p-PI3K/PI3K and p-Akt/Akt in liver tissues of mice between the metformin group and the normal group (P>0.05).Conclusion　Metformin can improve the obesity status of IR mice,improve the body′s ability to regulate blood glucose concentration,and reduce FINS level and HOMA-IR.The mechanism may be that metformin can alleviate IR by reducing the expression of FA and activating PI3K/Akt pathway in the liver.

参考文献/References:

［1］　ZATTERALE F,LONGO M,NADERI J,et al.Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes［J］.Front Physiol,2020,10:1607.
［2］　WEN C C,WU J S,CHEN C W,et al.Protective effect of vanillic acid against hyperinsulinemia,hyperglycemia and hyperlipidemia via alleviating hepatic insulin resistance and inflammation in high-fat diet (HFD)-fed rats［J］.Nutrients,2015,7(12):9946-9959.
［3］　REARDON CA,LINGARAJU A,SCHOENFELT K Q,et al.Obesity and insulin resistance promote atherosclerosis through an IFNγ-regulated macrophage protein network［J］.Cell Rep,2018,23(10):3021-3030.
［4］　ADACHI S I,YSHIZAWA F,YAGASAKI K.Hyperuricemia in type 2 diabetic model KK-A y/Ta mice:a potent animal model with positive correlation between insulin resistance and plasma high uric acid levels［J］.BMC Res Notes,2017,10(1):577.
［5］　SAEEDI P,PETERSOHN I,SALPEA P,et al.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045:results from the international diabetes federation diabetes atlas,9 th edition［J］.Diabetes Res Clin Pract,2019,157:107843.
［6］　KELLY T,YANG W,CHEN C S,et al.Global burden of obesity in 2005 and projections to 2030［J］.Int J Obes (Lond),2008,32(9):1431-1437.
［7］　OAKES N D,COONEY G J,CAMILLERI S,et al.Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding［J］.Diabetes,1997,46(11):1768-1774.
［8］　MORI K,EMOTO M,INABA M.Fetuin-A:a multifunctional protein［J］.Recent Pat Endocr Metab Immune Drug Discov,2011,5 (2):124-146.
［9］　OSAWA M,UMETSU K,SATO M,et al.Structure of the gene encoding human alpha 2-HS glycoprotein (AHSG)［J］.Gene,1997,196 (1-2):121-125.
［10］　JIRAKA P,STECHEMESSERB L,MOR E,et al.Clinical implications of fetuin-A［J］.Adv Clin Chem,2019,89:79-130.
［11］　YOO H J,CHOI K M.Hepatokines as a link between obesity and cardiovascular diseases［J］.Diabetes Metab J,2015,39 (1):10-15.
［12］　KROGER J,MEIDTNER K,STEFAN N,et al.Circulating fetuin-A and risk of type 2 diabetes:a mendelian randomization analysis［J］.Diabetes,2018,67(6):1200-1205.
［13］　TREPANOWSKI J F,MEY J,VARADY K A.Fetuin-A:a novel link between obesity and related complications［J］.Int J Obes (Lond),2015,39(5):734-741.
［14］　PETER A,KOVAROVA M,STAIGER H,et al.The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans［J］.Am J Physiol Endocrinol Metab,2018,314(3):E266-E273.
［15］　CELEBI G,GENC H,GUREL H,et al.The relationship of circulating fetuin-A with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease［J］.Saudi J Gastroenterol,2015,21(3):139-145.
［16］　WANG J,HE Y,YU D,et al.Perilla oil regulates intestinal microbiota and alleviates insulin resistance through the PI3K/AKT signaling pathway in type-2 diabetic KKAy mice［J］.Food Chem Toxicol,2020,135:110965.
［17］　HUANG X,LIU G,Guo J,et al.The PI3K/AKT pathway in obesity and type 2 diabetes［J］.Int J Biol Sci,2018,14(11):1483-1496.
［18］　LI M,HU X,XU Y,et al.A possible mechanism of metformin in improving insulin resistance in diabetic rat models［J］.Int J Endocrinol,2019,2019:3248527.
［19］　ZHANG X Y,GUO C C,YU Y X,et al.Establishment of high-fat diet-induced obesity and insulin resistance model in rats［J］.J Peking Univ (Health Sciences),2020,52(3):557-563.
［20］　PURKAYASTHA S,ZHANG H,ZHANG G,et al.Neural dysregulation of peripheral insulin action and blood pressure by brain endoplasmic reticulum stress［J］.Proc Natl Acad Sci U S A,2011,108(7):2939-2944.
［21］　YANG J H,LIM H S,HEO Y R.Sasa borealis leaves extract improves insulin resistance by modulating inflammatory cytokine secretion in high fat diet-induced obese C57/BL6J mice［J］.Nutr Res Pract,2010,4(2):99-105.
［22］　LU S,WANG H,REN R,et al.Reduced expression of twist 1 is protective against insulin resistance of adipocytes and involves mitochondrial dysfunction［J］.Sci Rep,2018,8(1):12590.
［23］　JUNG C H,KIM B Y,KIM C H,et al.Associations of serum fetuin-A levels with insulin resistance and vascular complications in patients with type 2 diabetes［J］.Diab Vasc Dis Res,2013,10(5):459-467.
［24］　REN G,KIM T,PAPIZAN J B,et al.Phosphorylation status of Fetuin-A is critical for inhibition of insulin action and is correlated with obesity and insulin resistance［J］.Am J Physiol Endocrinol Metab,2019,317(2):E250-E260.
［25］　SRINIVAS P R,WAGNER A S,REDDY L V,et al.Serum as-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level［J］.Mol Endocrinol,1993,7(11):1445-1455.
［26］　HUANG X,LIU G,GUO J,et al.The PI3K/AKT pathway in obesity and type 2 diabetes［J］.Int J Biol Sci,2018,14(11):1483-1496.
［27］　DARREN D M,DELERIVE P,SUMMERS R J,et al.Protein-coupled receptors targeting insulin resistance,obesity,and type 2 diabetes mellitus［J］.Pharmacol Rev,2017,70(1):39-67.
［28］　BELFORT R,MANDARINO L,KASHYAP S,et al.Dose-response effect of elevated plasma free fatty acid on insulin signaling［J］.Diabetes,2005,54(6):1640-1648.
［29］　KADOWAKI T,UEKI K,YAMAUCHI T,et al.Snapshot:insulin signaling pathways［J］.Cell,2012,148(3):624.
［30］　HENNESSY B T,SMITH D L,RAM P T,et al.Exploiting the PI3K/AKT pathway for cancer drug discovery［J］.Nat Rev Drug Discov,2005,4(12):988-1004.
［31］　HU X,WANG S,XU J,et al.Triterpenoid saponins from Staun tonia chinensis ameliorate insulin resistance via the AMP-activated protein kinase and IR/IRS1/PI3K/Akt pathways in insulin resis-tant HepG2 cells［J］.Int J Mol Sci,2014,15(6):10446-10458.
［32］　KOBAYASHI T,TAGUCHI K,NEMOTO S,et al.Activation of the PDK-1/Akt/eNOS pathway involved in aortic endothelial function differs between hyperinsulinemic and insulin-deficient diabetic rats［J］.Am J Physiol Heart Circ Physiol,2009,297 (5):H1767-H1775.
［33］　XIAN H M,CHE H,QIN Y,et al.Coriolus versicolor aqueous extract ameliorates insulinresistance with PI3K/Akt and p38 MAPK signaling pathways involved in diabetic skeletal muscle［J］.Phytother Res,2018,32 (3):551-560.
［34］　JIMNEZ-OSORIO A S,MONROY A,ALAVEZ S.Curcumin and insulin resistance-molecular targets and clinical evidences［J］.Biofactors,2016,42(6):561-580.
［35］　GARABADU D,KRISHNAMURTHY S.Metformin attenuates hepatic insulin resistance in type-2 diabetic rats through PI3K/Akt/GLUT-4 signalling independent to bicuculline-sensitive GABAA receptor stimulation［J］.Pharm Biol,2017,55(1):722-728.

相似文献/References:

[1]李怀祥,校庆志,王保琴,等.胰岛素抵抗与高血压病冠心病糖尿病[J].新乡医学院学报,1996,13(02):116.
[2]宋晓敏　杨　冰　杜　玮　郭长磊　李根旺　邬玉芳　郭丽萍.豆番粉与玉米粉对人体血糖胰岛素胰升血糖素的影响[J].新乡医学院学报,1998,15(03):234.
[3]秦海梅,杜玮,徐青.Graves病患者糖代谢紊乱60例临床观察[J].新乡医学院学报,2001,18(02):132.
[4]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[5]秦海梅,杜　玮,徐　青.2 型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[6]乔汉臣.非酒精性脂肪肝病研究进展[J].新乡医学院学报,2006,23(06):630.
[7]张 强,朱榕峰,刘 爽,等.高脂诱导非酒精性脂肪性肝病小鼠肝脏Chemerin及其受体的表达[J].新乡医学院学报,2009,26(03):224.
　ZHANG Qiang,ZHU Rong-feng,LIU Shuang,et al.Expression of Chemerin and it′s receptor in liver of mouse with nonalcoholic fatty liver disease induced by high fat diet[J].Journal of Xinxiang Medical University,2009,26(12):224.
[8]田莉娜.2型糖尿病伴非酒精性脂肪肝相关因素分析[J].新乡医学院学报,2010,27(04):394.
[9]王素平,陈 娟.老年原发性高血压患者胰岛素抵抗与颈动脉粥样硬化的关系 [J].新乡医学院学报,2012,29(10):798.
[10]马伏英１,樊毫军２,周小双１,等.有氧运动对高脂膳食金黄地鼠糖脂代谢及肝脏过氧化物酶增殖体受体的影响[J].新乡医学院学报,2014,31(05):343.[doi:10.7683/xxyxyxb.2014.05.006]
[11]张晓辉,张弛,刘浩钦.2型糖尿病患者合并甲状腺功能减退症的危险因素分析[J].新乡医学院学报,2023,40(3):234.[doi:10.7683/xxyxyxb.2023.03.007]
　ZHANG Xiaohui,ZHANG Chi,LIU Haoqin.Analysis of risk factors of hypothyroidism in patients with type 2 diabetes mellitus[J].Journal of Xinxiang Medical University,2023,40(12):234.[doi:10.7683/xxyxyxb.2023.03.007]

更新日期/Last Update: 2022-12-05